Skip to main content
. 2022 May 13;10:895288. doi: 10.3389/fbioe.2022.895288

TABLE 2.

Controlled release of antimicrobial agents on the PEEK-PDA (2 mg/ml dopamine hydrochloride) surface.

Ion Sample Method Bacterial strain Antibacterial test Antibacterial property Mechanism Biological effect Reference
AgNPs Tollens’ reagent (0.02 mol/L) [ammonia into AgNO3 solution (0.02 mol/L)] PEEK-PDA immersed in the Tollens’ reagent for 30 min E. coli , S. aureus, and S. aureus Plate counting and SEM IAI model in rat femur 97.9 ± 0.8% 99.8 ± 0.1% (antibacterial rate) S. aureus growth was significantly inhibited on the surface Fast Ag+ release initially, then slow release for long-term Showed low toxicity to MC3T3-E1 cell and possessed good biocompatibility and osseointegration Gao et al. (2017)
AgNPs、SF/GS AgNO3–gentamicin (500 lg/mL in PBS) and silk fibroin SP–PDA–Ag immersed into gentamicin followed by three silk layers E. coli and S. aureus Plate counting and SEM Greatly enhanced the antibacterial effects and antiadhesion ability The release rate of Ag+ and GS increased with decreasing pH PDA and silk fibroin can balance cytocompatibility and antibacterial ability Yan et al. (2018)
KR-12 KR-12 solution (1 mg/ml in 10 mM Tris–HCl buffer) PEEK-PDA immersed in KR-12 solution under reverse nitrogen (N2) flow overnight S. aureus and S. aureus Plate counting and SEM IAI model in rat femur Effectively inhibited bacteria proliferation and biofilm formation in vitro and in vivo Release of KR-12 which has a broad spectrum of antibacterial activity rBMSCs: improved adhesion, proliferation, and osteogenic differentiation; in vivo: promoted osteointegration in rat femur Meng et al. (2020)
GS PDA and GS diluted in Tris–HCl solution (2 mg/ml and 3 mg/ml) SPEEK was immersed in the left solution for 12 h E. coli , S. aureus, and S. aureus Plate counting IAI model in rat femur Continuous antibacterial abilities. Imaging showed no evidence of osteomyelitis GS release Possessed good biocompatibility and the immunoregulatory ability Sun et al. (2021)
Mino liposomes Minocycline (Mino), liposome, and dexamethasone (DEX) PEEK-PDA immersed in the Dex/Mino liposome solution obtained by the thin-film hydration method S. mutans, P. gingivalis, and S. mutans Plate counting and microbial viability assay kit-WST subcutaneous infection model of rats Improved the antibacterial activity and inhibited the initial adhesion. The antibacterial efficiency was about 97.4% Liposomal Mino releasing and benign cell adhesion on the functionalized PEEK surface In vitro, improved osteogenic differentiation of human mesenchymal stem cells. In vivo, enhanced osteointegration Xiao Xu et al. (2019)
Zn2+–Mg2+ Mg(NO3)2·6H2O、Zn(NO3)2·6H2O、2,5-dihydroxy-terephthalic acid (DHTA) dexamethasone (DEX) PEEK-PDA was dipped in Zn−Mg-MOF74 composite obtained by hydrothermal synthesis and then coated by DEX E. coli, S. aureus, and S. aureus Plate counting and SEM fluorescence microscope subcutaneous infection model of rats Significantly inhibited bacterial proliferation. Much smaller number of bacteria Mg2+, Zn2+, and DHTA release. The alkaline microenvironment due to the coating degradation Improved vascularization and osteogenic differentiation Xiao et al. (2021)
Van-GNPs vancomycin (Van)–Gelatin nanoparticles (GNPs) Plasma modification (PDA/P-PEEK) combines two-step desolvation (Van-GNPs) S. aureus and S. mutans Plate counting and SEM Inhibited bacteria adhesion and the cell membrane bursted on the Van-GNPs/PEEK surface Vancomycin release Good osteogenesis without cytotoxicity Tianjie Chen et al. (2021)
AgNPs–µCuO/SF Cu(NO3)2 •3H2O、AgNO3, Silk fibroin SPEEK μCuO was prepared by hydrothermal solution followed by polymerization E. coli and S. aureus Plate counting and SEM Effectively inhibited bacteria adhesion and biofilm formation Cu2+ and Ag+ release Showed better osteogenesis in the rabbit tibial defect model Yan et al. (2020)